Working to Eradicate Gynecologic Cancers

R. Wendel Naumann, MD

Director Minimally Invasive Surgery - Gyn Onc
Levine Cancer Institute
Division of Gynecologic Oncology
309 E. Morehead St
Apt 922
Charlotte, NC
USA 28202

Papers:
8 A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)